Login / Signup

Physicochemical and Functional Similarity Assessment Between Proposed Bevacizumab Biosimilar BAT1706 and Reference Bevacizumab.

Di CaoChunping DengGuangying WangXiong MeiJianhua XieYuanmei LiuYujie LiuYili YangShengfeng LiCuihua Liu
Published in: Drugs in R&D (2023)
Overall, this extensive comparability exercise demonstrated BAT1706 to match EU/US-bevacizumab in terms of all physicochemical and functional attributes assessed.
Keyphrases
  • metastatic colorectal cancer
  • high intensity
  • resistance training